STAT4 and hepatocellular carcinoma: Previous reports demonstrate that decreased levels of STAT4 as indicative of worse prognoses in hepatocellular carcinoma (16), while high STAT4 expression has been linked to reduced tumor recurrence (17), and improved stage 3 prognosis in patients with gastric cancer (18).